Live life on your toes, not your heels, says Lynn O’Connor Vos, CEO of Grey Healthcare Group. Each day offers a new opportunity to invest in the way the industry communicates—and reinvent the way people think. Of course you’ll grow the business. Along the way, don’t forget to grow yourself.
Listen to more Women of the Year podcast Series>>>
Beyond the Birthrate: The Societal Costs of Maternal Mortality
September 6th 2024Head of Medical Affairs and Outcomes Research at Organon, Charlotte Owens, MD, FACOG, discusses the most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make.
Efsitora Demonstrates Non-Inferiority vs. Insulin Glargine, Degludec for Type 2 Diabetes
September 5th 2024Results from the QWINT-1 and QWINT-3 trials found that insulin-naïve patients achieved similar reductions in A1C levels using once-weekly efsitora compared to daily insulin glargine and degludec.